Skip to main content
icon for Will Teladoc Health (TDOC) beat quarterly earnings?
Доход·Акции

Will Teladoc Health (TDOC) beat quarterly earnings?

icon for Will Teladoc Health (TDOC) beat quarterly earnings?
Доход·Акции

Will Teladoc Health (TDOC) beat quarterly earnings?

июл. 29

июл. 29

50% вероятность
Polymarket
НОВОЕ
50% вероятность
Polymarket
НОВОЕ
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Teladoc Health (TDOC) faces a closely balanced market-implied 50% probability of beating Q2 2026 earnings, scheduled for release after the July 29 close. Recent Q1 results showed an EPS miss at -$0.36 against consensus near -$0.32 alongside a modest revenue beat to $613.85 million, highlighting persistent profitability pressures amid softer BetterHelp volumes and elevated operating costs. Trader sentiment reflects this tension, with analysts maintaining a Hold consensus and price targets clustered near $7–10, while recent share-price gains of over 20% post-Q1 signal improving momentum. Key swing factors include potential upside in integrated care revenue or cost discipline that could exceed the projected EPS loss near -$0.24; any pre-release guidance revisions or utilization data could shift odds ahead of the report.

As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.

If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Объем
$0
Дата окончания
29 июл. 2026 г.
Открытие рынка
Jul 15, 2026, 8:52 PM ET

Источник определения исхода

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Teladoc Health (TDOC) faces a closely balanced market-implied 50% probability of beating Q2 2026 earnings, scheduled for release after the July 29 close. Recent Q1 results showed an EPS miss at -$0.36 against consensus near -$0.32 alongside a modest revenue beat to $613.85 million, highlighting persistent profitability pressures amid softer BetterHelp volumes and elevated operating costs. Trader sentiment reflects this tension, with analysts maintaining a Hold consensus and price targets clustered near $7–10, while recent share-price gains of over 20% post-Q1 signal improving momentum. Key swing factors include potential upside in integrated care revenue or cost discipline that could exceed the projected EPS loss near -$0.24; any pre-release guidance revisions or utilization data could shift odds ahead of the report.

As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.

If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Объем
$0
Дата окончания
29 июл. 2026 г.
Открытие рынка
Jul 15, 2026, 8:52 PM ET

Источник определения исхода

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Связанные

icon for Выиграют ли Milwaukee Brewers титул чемпиона Центрального дивизиона НЛ в 2026 году

Выиграют ли Milwaukee Brewers титул чемпиона Центрального дивизиона НЛ в 2026 году

78%
Да
icon for Saturn FDV above $50M one day after launch

Saturn FDV above $50M one day after launch

79%
icon for Will Germany GDP growth in Q2 2026 be between 0.4% and 0.6%?

Will Germany GDP growth in Q2 2026 be between 0.4% and 0.6%?

44%

Не доверяй внешним ссылкам.

Часто задаваемые вопросы

«Will Teladoc Health (TDOC) beat quarterly earnings?» — это рынок прогнозов на Polymarket, где трейдеры покупают и продают акции «Да» или «Нет» в зависимости от того, верят ли они, что это событие произойдёт. Текущая вероятность по мнению сообщества составляет 50% для «Yes». Например, если «Да» торгуется по 50¢, рынок коллективно оценивает вероятность наступления события в 50%. Эти коэффициенты постоянно меняются по мере реакции трейдеров на новые события и информацию. Акции правильного исхода можно обменять на $1 каждую при разрешении рынка.

«Will Teladoc Health (TDOC) beat quarterly earnings?» — недавно созданный рынок на Polymarket, запущен Jul 15, 2026. Как ранний рынок, это твоя возможность быть среди первых трейдеров, устанавливающих коэффициенты и формирующих начальные ценовые сигналы. Ты также можешь добавить эту страницу в закладки, чтобы следить за объёмом и активностью торгов.

Чтобы торговать на «Will Teladoc Health (TDOC) beat quarterly earnings?», просто выбери, считаешь ли ты, что ответ — «Да» или «Нет». Каждая сторона имеет текущую цену, отражающую подразумеваемую вероятность рынка. Введи сумму и нажми «Торговать». Если ты купишь акции «Да» и исход разрешится как «Да», каждая акция принесёт $1. Если исход — «Нет», твои акции «Да» принесут $0. Ты также можешь продать свои акции в любой момент до разрешения, чтобы зафиксировать прибыль или ограничить убыток.

Текущая вероятность для «Will Teladoc Health (TDOC) beat quarterly earnings?» составляет 50% для «Yes». Это означает, что сообщество Polymarket в настоящее время оценивает вероятность наступления этого события в 50%. Эти коэффициенты обновляются в реальном времени на основе реальных сделок, предоставляя постоянно обновляемый сигнал ожиданий рынка.

Правила разрешения «Will Teladoc Health (TDOC) beat quarterly earnings?» точно определяют, что должно произойти, чтобы каждый исход был объявлен победителем, включая официальные источники данных, используемые для определения результата. Ты можешь просмотреть полные критерии разрешения в разделе «Правила» на этой странице над комментариями. Мы рекомендуем внимательно прочитать правила перед торговлей, так как они определяют точные условия, особые случаи и источники.